Aiming to bring life-saving low-dose lung screenings to underserved areas of the United States, NeuroLogica announced a partnership with Winnebago Industries Inc. to provide access to mobile computed tomography (CT) clinics across America. The units will feature NeuroLogica’s BodyTom Elite, the world’s first portable, full-body, 32-slice CT scanner on board a J38S Winnebago commercial vehicle platform, from Winnebago’s Specialty Vehicle Division. The mobile CT clinics will offer health care providers the ability to perform low-dose lung cancer screenings and travel city-to-city to improve access to lung diagnostic services.
NeuroLogica and Winnebago displayed a mobile lung screening clinic at the 2018 Radiological Society of North America’s Annual Meeting (RSNA) in Chicago, Illinois, from November 25-30, 2018.
“We are proud to increase access to low-dose lung screenings through our partnership with Winnebago,” said David Webster, NeuroLogica’s chief operating officer. “This is an important step toward delivering high-quality care to patients in the community, especially those patients beyond a healthcare systems’ immediate service area.”
The mobile CT clinic will feature a BodyTom Elite, the world’s first portable, battery-powered, full-body, 32-slice CT scanner, optional all-electric/zero-emission powertrains will be available through Winnebago’s partnership with Motiv Power Systems. A Lithium-ion battery-based energy management system from Volta Power Systems, which will replace the traditional generator for onboard power and reduce vehicle emissions, will also be included. It will also feature vehicle upfit and customization through Summit Bodyworks Specialty Vehicles, a Denver-based custom vehicle upfitter.
“Winnebago has always been a market leader and industry innovator,” said Jamie Sorenson, Winnebago’s Director of Specialty Vehicles and Advanced Technology. “This year, Winnebago celebrated being in business for 60 years, and for more than 40 of those years, Winnebago has produced commercial vehicles for all types of applications, with a focus on mobile outreach. This partnership with NeuroLogica represents the next evolution in mobile healthcare innovation and has the potential to dramatically change a person’s life.”
